← Back to Patent Explorer
US4109013A Expired / Lapsed US ⏱️ 0.0 years remaining

Substituted propanol-(2) derivatives of hydroxamic acids and the use thereof as hypolipemic drugs

Assignee: Astellas Deutschland GmbH
•
Filing: 1977-11-09
•
Granted: 1978-08-22
•
Expires: 1997-11-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract New 1,3-disubstituted propanol-(2) derivatives and their nicotinic acid esters of the general formula ##STR1## and their therapeutically acceptable salts, processes for preparing the same and the use thereof and pharmaceutical preparations containing the same for the treatment of hyperlipemia.

Inventors

  • 👤 Helmut Grill
  • 👤 Rainer Hans Zschocke
  • 👤 Josef Wagner
  • 👤 Gernot Hofrichter
  • 👤 P. Stefan Janiak

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 01:02
CPC Classifications
C; C07; C07D; C07D213/00; C07D213/02; C07D213/04; C07D213/24; C07D213/28; C07D213/30; C07C; C07C323/00; C07D213/60; C07D213/78; C07D213/79; C07D213/80; C07D317/00; C07D317/08; C07D317/10; C07D317/14; C07D317/18; C07D317/22

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 51 words
A 1,3-disubstituted propanol-(2) derivative of the general formula ##STR33## or its therapeutically acceptable salt, where X and Y stand for --O--; R 1 = --Cl, or --C(CH 3 ) 3 ; R 2 = --h; a = a valence bond, a vinylene group, or an ethylene group; R 3 = --conhoh.
Claim 2
Dependent Claim 51 words
A 1,3-disubstituted propanol-(2) derivative of the general formula ##STR33## or its therapeutically acceptable salt, where X and Y stand for --O--; R 1 = --Cl, or --C(CH 3 ) 3 ; R 2 = --h; a = a valence bond, a vinylene group, or an ethylene group; R 3 = --conhoh.
Claim 3
Dependent Claim 35 words
the compound of claim 1, where X and Y stand for --O--; R 1 = --cl, or --C(CH 3 ) 3 ; R 2 = --h; a = a valence bond; R 3 = --conhoh.
Claim 4
Dependent Claim 1 words
3-(4'-(n-hydroxycarbamoyl)-phenoxy)-1-(4'-t.-butylphenoxy)-propanol-(2).
Claim 5
Dependent Claim 1 words
3-(4'-(n-hydroxycarbamoyl)-phenoxy)-1-(4'-t.-butylphenoxy)-propanol-(2).
Claim 6
Dependent Claim 29 words
A medicinal composition, for the treatment of hyperlipemia containing an effective amount of a compound according to claim 1 as the active substance together with a pharmaceutically acceptable carrier.
Claim 7
Dependent Claim 22 words
Medicinal composition according to claim 4, characterized in that the single dose of the particular medicinal form contains 10-500 mg active substance.
Claim 8
Dependent Claim 13 words
A medicinal composition according to claim 5, wherein the active substance is 3-(4'-(N-hydroxycarbamoyl)-phenoxy)-1-(4'-t.-butylphenoxy)-propanol-(2).
Claim 9
Dependent Claim 27 words
A method for treating hyperlipemia which comprises administering to a subject in need of such treatment, a therapeutically effective dose of a compound according to claim 1.

References Cited (Backward Citations)

US3641123A Cited
US3927092A Cited
US3600437A Cited
US3845109A Cited
US3819702A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-08-21 1982-02-20 1982-08-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-08-21 1986-02-20 1986-08-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-08-21 1990-02-20 1990-08-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag